Back
CoStar Group 10K Form
Buy
61
CSGP
CoStar Group
Last Price:
78.64
Seasonality Move:
10.19%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-24 | 10Q | CSGP/CoStar Group Quarterly |
2023-10-25 | 10Q | CSGP/CoStar Group Quarterly |
2023-07-26 | 10Q | CSGP/CoStar Group Quarterly |
2023-04-26 | 10Q | CSGP/CoStar Group Quarterly |
2022-10-26 | 10Q | CSGP/CoStar Group Quarterly |
2022-07-27 | 10Q | CSGP/CoStar Group Quarterly |
Receive CSGP News And Ratings
See the #1 stock for the next 7 days that we like better than CSGP
CSGP Financial Statistics
Sales & Book Value
Annual Sales: | $2.46B |
---|---|
Cash Flow: | $13.7M |
Price / Cash Flow: | 0 |
Annual Sales: | $18.29 |
Price / Book: | 4.3 |
Profitability
EPS (TTM): | 0.44000 |
---|---|
Net Income (TTM): | $175.4M |
Gross Margin: | $1.96B |
Return on Equity: | 2.39% |
Return on Assets: | 1.95% |
CoStar Group Earnings Forecast
Key CoStar Group Financial Ratios
- The Gross Profit Margin over the past 27 years for CSGP is 79.98%.
- The Selling, General & Administrative Expenses for CSGP have been equal to 55.86% of Gross Profit Margin.
- The Research & Development expenses have been 10.90% of Revenue.
- The Interest Expense is 0.83% of Operating Income.
- The Net Earning history of CSGP is 15.26% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 16 years.
CoStar Group Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Real Estate Management & Development |
Sector: | Real Estate |
Current Symbol: | CSGP |
CUSIP: | 22160N |
Website: | costar.com |
Debt
Debt-to-Equity Ratio: | 0.13 |
---|---|
Current Ratio: | 9.63 |
Quick Ratio: | 9.49 |
Price-to-Earnings
Trailing P/E Ratio: | 85.49 |
---|---|
Forward P/E Ratio: | 69.49 |
CSGP Technical Analysis vs Fundamental Analysis
Buy
61
CoStar Group (CSGP)
is a Buy
Is CoStar Group a Buy or a Sell?
-
CoStar Group stock is rated a Buy
The current CoStar Group [CSGP] share price is $78.65. The Score for CSGP is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.